Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M845Revenue $M89.3Net Margin (%)-165.8Altman Z-Score-4.5
Enterprise Value $M917EPS $-1.3Operating Margin %-145.2Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.7Pre-tax Margin (%)-165.6Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio1.9Cash flow > EarningsY
Price/Sales9.05-y EBITDA Growth Rate %-31.9Current Ratio1.9Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-101.6Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M116ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with MACK

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MACKJoel Greenblatt 2015-06-30 Sold Out $10.76 - $13.67
($12.09)
$ 7.28-40%Sold Out0
MACKJoel Greenblatt 2015-03-31 Buy $8.78 - $12.48
($10.82)
$ 7.28-33%New holding13,433
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MACK is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


MACK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
PORTER MICHAEL EDirector 2016-03-17Buy5,000$7.21.11view
PORTER MICHAEL EDirector 2016-03-15Buy5,000$7.65-4.84view
PORTER MICHAEL EDirector 2016-03-08Buy10,000$7.092.68view
PORTER MICHAEL EDirector 2016-03-03Buy15,000$6.3913.93view
PORTER MICHAEL EDirector 2016-03-01Buy20,000$6.1119.15view
Lee Vivian SDirector 2016-02-29Buy35,000$5.532.36view
McClements William M.Head of Corporate Operations 2016-02-29Buy2,000$5.7227.27view
Stewart Edward J.Head of Commercial 2016-01-05Sell4,000$8-9view
Stewart Edward J.Head of Commercial 2015-12-01Sell5,000$9.33-21.97view
Stewart Edward J.Head of Commercial 2015-11-02Sell6,000$9.42-22.72view

Quarterly/Annual Reports about MACK:

    News about MACK:

    Articles On GuruFocus.com
    Weekly CEO Sells Highlight: Starbucks Corp, KD Supply Holdings Inc, Capital One Financial Corp, Merr Dec 14 2014 

    More From Other Websites
    Merrimack Reports First Quarter 2016 Financial Results May 02 2016
    Merrimack reports 1Q loss May 02 2016
    Merrimack reports 1Q loss May 02 2016
    MERRIMACK PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... May 02 2016
    4:04 pm Merrimack Pharma beats by $0.05, misses on revs; reiterates FY16 guidance May 02 2016
    Merrimack Reports First Quarter 2016 Financial Results May 02 2016
    Q1 2016 Merrimack Pharmaceuticals Inc Earnings Release - After Market Close May 02 2016
    Drug Stocks Q1 Earnings Preview: AEGR, AERI, MACK, PRTA Apr 29 2016
    ETF’s with exposure to Merrimack Pharmaceuticals, Inc. : April 28, 2016 Apr 28 2016
    Merrimack (MACK) Q1 Earnings: What's Ahead for the Stock? Apr 27 2016
    Merrimack Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : MACK-US :... Apr 27 2016
    Merrimack Unveils its Latest Antibody Directed Nanotherapeutic, MM-310, at the 2016 AACR Annual... Apr 21 2016
    Merrimack Unveils its Latest Antibody Directed Nanotherapeutic, MM-310, at the 2016 AACR Annual... Apr 21 2016
    Merrimack Announces Timing of First Quarter 2016 Investor Conference Call Apr 20 2016
    Merrimack Announces Timing of First Quarter 2016 Investor Conference Call Apr 20 2016
    Leica Biosystems and Merrimack Pharmaceuticals to Collaborate on Development of a Heregulin... Apr 14 2016
    Leica Biosystems and Merrimack Pharmaceuticals to Collaborate on Development of a Heregulin... Apr 14 2016
    What Is Going On With These Falling Stocks? Apr 14 2016
    MERRIMACK PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement,... Apr 14 2016
    Zacks Investment Ideas feature highlights: Juno Therapeutics, Genocea Biosciences, Merrimack... Apr 11 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)